News
Edwards Lifesciences has claimed a groundbreaking approval from the FDA that opens up its minimally invasive heart valve ...
My husband and I recently welcomed our new granddaughter. She is 2 months old and therefore several months away from ...
The agency’s decision for the balloon-expandable Sapien 3 platform is based on groundbreaking results from EARLY TAVR.
11h
MedPage Today on MSNFDA Approves Sapien 3 TAVR for Asymptomatic Aortic StenosisFDA approved the Sapien 3 transcatheter aortic valve replacement (TAVR) platform for treatment of severe aortic stenosis ...
Edwards Lifesciences announced the FDA approved its transcatheter aortic valve replacement platform for treatment of severe ...
Edwards Lifesciences (NYSE: EW) received FDA approval for its Sapien 3 TAVR for severe aortic stenosis (AS) without symptoms.
9h
Medical Device Network on MSNFDA approves Edwards’ TAVR system for asymptomatic aortic stenosis patientsEdwards’ SAPIEN 3 platform becomes the first TAVR system approved by the FDA for asymptomatic severe aortic stenosis patients ...
The septum separates the right-hand and left-hand side of the heart. The tricuspid valve separates the right atrium and right ventricle. It opens due to a build-up of pressure in the right atrium ...
10h
SussexWorld on MSNCardiac team triumphs with ‘breakthrough’ heart valve replacement for Lewes patientSevere tricuspid valve regurgitation is a serious heart condition. The development of tricuspid valve implants is still in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results